Becton Dickinson EBITDA 2011-2025 | BDX
Becton Dickinson annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Becton Dickinson EBITDA for the quarter ending September 30, 2025 was $1.500B, a 28.21% increase year-over-year.
- Becton Dickinson EBITDA for the twelve months ending September 30, 2025 was $4.926B, a 11.65% increase year-over-year.
- Becton Dickinson 2024 annual EBITDA was $4.684B, a 6.48% increase from 2023.
- Becton Dickinson 2023 annual EBITDA was $4.399B, a 2.5% decline from 2022.
- Becton Dickinson 2022 annual EBITDA was $4.512B, a 0.69% increase from 2021.
|
Becton Dickinson Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $4,684 |
| 2023 | $4,399 |
| 2022 | $4,512 |
| 2021 | $4,481 |
| 2020 | $3,027 |
| 2019 | $4,013 |
| 2018 | $3,487 |
| 2017 | $2,610 |
| 2016 | $2,544 |
| 2015 | $1,965 |
| 2014 | $2,168 |
| 2013 | $1,801 |
| 2012 | $2,069 |
| 2011 | $2,159 |
|
Becton Dickinson Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,500 |
| 2025-03-31 | $1,155 |
| 2024-12-31 | $1,061 |
| 2024-09-30 | $1,210 |
| 2024-06-30 | $1,170 |
| 2024-03-31 | $1,305 |
| 2023-12-31 | $999 |
| 2023-09-30 | $938 |
| 2023-06-30 | $1,118 |
| 2023-03-31 | $1,190 |
| 2022-12-31 | $1,153 |
| 2022-09-30 | $1,070 |
| 2022-06-30 | $1,091 |
| 2022-03-31 | $1,114 |
| 2021-12-31 | $1,237 |
| 2021-09-30 | $666 |
| 2021-06-30 | $1,027 |
| 2021-03-31 | $991 |
| 2020-12-31 | $1,797 |
| 2020-09-30 | $197 |
| 2020-06-30 | $893 |
| 2020-03-31 | $906 |
| 2019-12-31 | $1,031 |
| 2019-09-30 | $665 |
| 2019-06-30 | $1,200 |
| 2019-03-31 | $699 |
| 2018-12-31 | $1,449 |
| 2018-09-30 | $1,142 |
| 2018-06-30 | $1,079 |
| 2018-03-31 | $740 |
| 2017-12-31 | $526 |
| 2017-09-30 | $777 |
| 2017-06-30 | $55 |
| 2017-03-31 | $706 |
| 2016-12-31 | $1,072 |
| 2016-09-30 | $370 |
| 2016-06-30 | $788 |
| 2016-03-31 | $745 |
| 2015-12-31 | $641 |
| 2015-09-30 | $610 |
| 2015-06-30 | $436 |
| 2015-03-31 | $431 |
| 2014-12-31 | $488 |
| 2014-09-30 | $550 |
| 2014-06-30 | $587 |
| 2014-03-31 | $511 |
| 2013-12-31 | $520 |
| 2013-09-30 | $219 |
| 2013-06-30 | $544 |
| 2013-03-31 | $517 |
| 2012-12-31 | $521 |
| 2012-09-30 | $516 |
| 2012-06-30 | $572 |
| 2012-03-31 | $511 |
| 2011-12-31 | $470 |
| 2011-09-30 | $494 |
| 2011-06-30 | $567 |
| 2011-03-31 | $563 |
| 2010-12-31 | $536 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $50.974B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.974B | 23.49 |
| Cardinal Health (CAH) | United States | $48.391B | 22.86 |
| West Pharmaceutical Services (WST) | United States | $19.499B | 38.34 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.310B | 0.00 |
| Cooper (COO) | United States | $13.937B | 17.44 |
| Align Technology (ALGN) | United States | $9.675B | 18.27 |
| Henry Schein (HSIC) | United States | $8.464B | 14.92 |
| Merit Medical Systems (MMSI) | United States | $5.191B | 25.52 |
| DENTSPLY SIRONA (XRAY) | United States | $2.230B | 7.08 |
| CONMED (CNMD) | United States | $1.361B | 9.73 |
| STAAR Surgical (STAA) | United States | $1.321B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.101B | 12.04 |
| Lifevantage (LFVN) | United States | $0.094B | 8.92 |